Registration Options

Activity Dates: 04/27/2020 - 04/27/2023

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

In the US, deaths due to suicide and unintentional overdose are on the rise and pose an urgent public health concern. In 2017, over 40% of suicide and overdose deaths, so-called “Deaths of Despair”, were due to opioids. This represents a 2-1/2 fold increase from 17% in 2000.1 Pain alters neurocircuitry and increases the risk of suicide, which may be unknown to many psychiatric pharmacists. There are several key shared risk factors and prevention approaches that should be known by psychiatric pharmacists. By understanding these key risk factors, pharmacists can better identify patients at greatest risk. By learning key prevention approaches, pharmacists can intervene and save the lives of patients in their care by preventing unintentional overdoses and deaths by suicide.

As a response to legislation and other pressures, many patients are having opioid therapy rapidly tapered or abruptly terminated by their providers. Many psychiatric pharmacists may be unfamiliar with various opioid tapering strategies and which is best for a given patient. Knowledge of the principles of compassionate opioid tapering can help pharmacists treat patients and educate other providers about best opioid practices.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Evaluate the links between opioid use, chronic pain, suicide, and the subsequent impact on patient care.
  2. Describe prevention strategies for unintentional opioid overdose and suicide.
  3. Disseminate knowledge on the principles of ethical and compassionate opioid tapering aimed at reducing unintentional overdose and suicide.

Continuing Education Credit and Disclosures

Activity Dates: 04/27/2020 - 04/27/2023
ACPE Contact Hours: 1
ACPE Number: 0284-0000-20-016-H08-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.